UCLA surgeons find new way to shield vision during radiation for eye cancer

Jul 12, 2010

Eye cancer patients face an unenviable dilemma. They must enter treatment knowing that their surgeon's strategy to kill the deadly tumor with radiation may also sacrifice their eyesight.

Now, UCLA researchers have discovered that a commonly used substance called silicon oil shields the eye and appears to protect vision in patients undergoing radiation therapy for . The American Medical Association's publishes the findings in its July edition.

"Vision loss is a devastating yet common side effect of radiation therapy," said Dr. Tara McCannel, assistant professor of ophthalmology and director of the UCLA Ophthalmic Oncology Center at the Jules Stein Eye Institute. "Until recently, physicians focused on killing the tumor and considered vision loss secondary. Our results suggest that silicon oil offers a safe tool for protecting the patient's vision during radiation."

Ocular melanoma forms in the pigmented layers under the retina and is the most common to strike adults. The National Eye Institute reports some 2,000 newly diagnosed cases of the cancer, roughly seven in 1 million people, each year. The cause remains unknown.

Surgeons treat ocular melanoma by stitching a gold plaque containing radioactive seeds to the white of the eye and removing it a few days later. While radiation kills the , it also causes irreversible injury to the optic nerve fibers and macula, the section of the retina responsible for central vision.

to the macula weakens the blood vessels feeding the eye, causing bleeds and wiping out circulation. Even when the radiation successfully destroys the tumor, the eye structures remain extremely fragile and prone to atrophy, which can lead to vision loss.
"If patients survive the cancer, more than half will suffer vision loss in the treated eye six months to three years later," said McCannel, a vitreoretinal surgeon who is also a member of UCLA's Jonsson Comprehensive Cancer Center. The risk for blindness increases over time.

The UCLA technique takes place immediately before the patient's eye is exposed to radiation.

Patients first undergo an exam to measure baseline vision before treatment. McCannel next removes the vitreous gel, which supports the interior shape of the eye. She replaces the gel with silicon oil, an FDA-approved substance often used to hold the retina in place during surgery to repair retinal detachment.

After removing the radiation plaque from the treated eye, she flushes the oil away with saline, which is eventually replaced by the patient's natural fluids.

"We discovered that silicon oil absorbs nearly 50 percent of the radiation," she said. "The substance acts like a physical shield, reducing the amount of radioactive rays that reach the back and sides of the eye. We hope that silicon oil's ability to block radiation translates into better vision for patients down the road."

Already widely used in retinal surgery, the oil doesn't interfere with the tumor's treatment, and its transparency allows both the surgeon and the patient to see through it.

The UCLA team used three approaches to demonstrate that silicon oil absorbs 50 percent of the radiation rays. While more long-term research is needed, early follow-up with McCannel's patients showed that their vision returned to baseline levels without interfering with their tumors' response to radiation therapy.

Explore further: Aid group: Ebola contagion risk can't be zero

Provided by University of California - Los Angeles

5 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

FDA approves new LASIK device

Jul 12, 2007

The U.S. Food and Drug Administration has approved the first LASIK device designed to treat one eye for distance vision and the other eye for close vision.

Recommended for you

Aid group: Ebola contagion risk can't be zero

6 minutes ago

Despite stringent infection-control measures, the risk of Ebola's spread cannot be entirely eliminated, Doctors Without Borders said Friday after one of its doctors caught the dreaded disease while working in Guinea and went ...

WHO eyes mass Ebola vaccines by mid-2015

16 minutes ago

Hundreds of thousands of Ebola vaccine doses could be rolled out to west Africa by the middle of next year, the World Health Organization said Friday, after new cases of the killer virus were reported in New York and Mali.

User comments : 0